Pharmacy Report Archives - Page 11 of 153 - Becker's Hospital Review

Pharmacy's opportunity overload | 6 pharmacy projects moving the needle | Hospital specialty pharmacies double footprint | GLP-1s eclipse oncology in pipelines | New Alzheimer's drug cleared

Plus: HHS to curb psychiatric overprescribing May 5, 2026 1. How opportunity overload is reshaping pharmacy leadership Full story 2. 6 pharmacy-led projects with meaningful clinical outcomes Full story 3. Inventory gaps, workflow pressure, compliance demands…sound familiar? Discover how pharmacists…

Pharmacy's compliance playbook | Cuban's healthcare strategy | Pharmacist indicted for digital snooping | Court blocks mifepristone mailing | FDA names acting vaccines chief

Plus: GLP-1 use linked to fewer ulcers May 4, 2026 1. The new compliance playbook: How pharmacy leaders are driving change Full story 2. Mark Cuban's healthcare playbook, explained Full story 3. Chief Pharmacy Officers are being asked to lead…

What could break pharmacy by 2035 | GLP-1 compounding under fire | Judge permanently strikes ND 340B law | Drug spend to top $1 trillion | 10 systems hiring pharmacy leaders

Plus: GLP-1s show promise in addiction treatment April 30, 2026 1. What could make or break pharmacy by 2035 Full story 2. FDA seeks to restrict compounding of key GLP-1s Full story 3. Pharmacy procurement breaks at scale. See how…

Cracking the GLP-1 adherence code | Drug shortages climb in 2026 | OxyContin maker hit with $5B+ fine | Pancreatic cancer pill, vaccine show early promise | 10 states with highest, lowest drug use

Plus: FDA approves 1st 2-drug HIV treatment April 29, 2026 1. 3 barriers to GLP-1 adherence — and how systems are overcoming them Full story 2. US drug shortages trending upward in 2026 Full story 3. 80% of health systems…

Trump drug pricing impact to hit in 18 months | AHA fights Lilly's 340B data request: 5 notes | Employers' GLP-1 coverage dilemma | FDA weighs pulling Amgen drug | Utah board moves to halt AI Rx pilot

Plus: 6 big pharma moves April 28, 2026 1. Novartis CEO: Trump drug pricing impact to hit in 18 months Full story 2. AHA urges HHS to block Eli Lilly's 340B data demands: 5 things to know Full story 3.…

How to fix the pharmacy tech pipeline | J&J adds 4 drugs to TrumpRx | Last major drugmaker joins White House pricing push | FDA OKs 1st gene therapy for genetic hearing loss | Cuban inks deal with Eliquis

Plus: Justice Department reclassifies marijuana products April 27, 2026 1. What's broken in the pharmacy tech pipeline — and how leaders would repair it Full story 2. Johnson & Johnson to add 4 drugs to TrumpRx Full story 3. Hear…

3 pillars shaping pharmacy's future | Top 15 specialty pharmacies | Novo eyes Ozempic pill for children | 10 systems hiring pharmacy leaders | How Jefferson tackles GLP-1 coverage strain

Plus: What is ibogaine? 4 things to know April 23, 2026 1. 3 pillars shaping the future of pharmacy Full story 2. Top 15 specialty pharmacies of 2025: Report Full story 3. Payer strategies for specialty drug benefits are shifting.…

Pharmacy leaders eye 2030 revenue lifelines | Optum Rx cuts prior auth to 30 seconds | Retailers ramp up GLP-1 push | Senate targets Trump drug deals | CVS warns of closures after Tenn. PBM law

Plus: CMS pauses weight-loss BALANCE model for Medicare April 22, 2026 1. 10 pharmacy leaders on revenue streams that will define survival by 2030 Full story 2. Optum Rx's prior auth tool cuts prescription approvals from 8 hours to 30 seconds…

AHA to HRSA: Axe $1B+ 340B model | Wegovy scripts jump 50% | Amazon launches GLP-1 program | Blue Shield taps pharmacy chief from Kaiser | 45 state AGs back PBM transparency

Plus: Great leaders in healthcare | 2026 April 21, 2026 1. AHA urges HRSA to axe 340B model that would cost hospitals $1B+ a year Full story 2. Wegovy prescriptions jump 50%: 5 notes Full story 3. Health systems are…

Cuban eyes hospital-based drug manufacturing | Trump aims to fast-track psychedelic drugs | Senate flags continued drug price hikes | Study spots new GLP-1 side effects | Xanax recalled over quality issue

Plus: How vertical integration is reshaping pharmacy, payer landscape April 20, 2026 1. Mark Cuban wants to bring drug manufacturing to hospitals' doorsteps — literally Full story 2. Drugmakers raise prices despite Trump deals, Senate report finds Full story 3. Find…